Loading clinical trials...
Loading clinical trials...
This nationwide, multicenter observational study aims to develop and validate a multimodal artificial intelligence (AI) model for detecting occult lymph node metastasis in early-stage non-small cell l...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fudan University
NCT07333560 · Artificial Intelligence (AI), Machine Learning, and more
NCT07528274 · NSCLC (Non-small Cell Lung Cancer), NSCLC (Advanced Non-small Cell Lung Cancer)
NCT06253871 · HER2 Mutation-Related Tumors, HER2, and more
NCT07505719 · Artificial Intelligence (AI), Health Literacy, and more
NCT07075679 · Breast Cancer Screening, Artificial Intelligence (AI), and more
Fudan university Shanghai Cancer Center
Shanghai
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions